Immunization Recommendations Flashcards
Administration for all vaccines are typically ___ ml, intramuscular or subcutaneous, depending on the vaccine, with the exception of Influenza vaccine
0.5 ml
The first dose must be _______ vaccine
monovalent
Vaccine intervals need to be at least ___ weeks
6
_______ vaccination series of 3 (0-2-6)
Hepatitis B Vaccination
Hepatitis B Vaccination in all newborns the first dose before _____ discharge
hospital
The second dose of Hepatitis B Vaccine given at ___ months of age; monovalent or a combination vaccine containing Hep B
1 to 2 months
In infants born to Hepatitis B antigen (_____) positive mothers
HBsAg
Administer hepatitis B vaccine (___) and 0.5 ml hepatitis B immune globulin (HBIG) within 12 hours of birth
HepB
Test for _____ and antibody to HBsAg after three or more doses of HepB series (at age 9 to 18 months)
HBsAg
If the mother’s HBsAg status is unknown:
1) Determine/check status immediately after birth
2) Administer HepB within ____ hours of birth
3) If the mother test positive, HBIG should be given no later than 1 week of age
12 hours
The final dose of Hepatitis B vaccine should be given at ___ months of age or later
6 months
______ vaccine (Rota)
Rotavirus
Rotavirus Vaccine (Rota) series for this is?
Series of 3 from 6 weeks to 32 weeks
Administer the first dose of Rotavirus at ____ weeks and each subsequent dose at 4 weeks interval
6 to 14 weeks
Must complete the Rotavirus before ___ weeks
32 weeks
Do not administer a dose of Rotavirus after the age of ____ weeks?
32 weeks
Diptheria/ tetanus /pertussis vaccine (DTaP) series of 3 primaries at what ______ and two boosters at ( 15 months and 6 years)
2-4-6 months
DTaP is not indicated for children ___ years of age or older
7 years
Series of 1 (11 or 12 years)
1) Subsequent Td boosters are recommended every 10 years
Tetanus, Diptheria, Acellular Pertussis Vaccine (Tdap)
Series of 3 primaries (2-4-6 months) and one booster (12 months)
PCV 13 (Prevnar)
Children age 24 to 59 months who completed PCV 13 series and who are immune-compromised (one of following conditions) should receive an additional one dose of 23 PS at 24 months of age if they have the following: a) Hemoglobinopathies b) Asplenia c) Splenic dysfunction d) HIV infection e) Congenital immunodeficiencies f) Renal failure g) Nephrotic syndrome h) chronic cardiac disease I) chronic pulmonary disease j) diabetes k) Consider in this age group if of Native American, African American, or Alaskan descent, or attending daycare
23PS (Pneumovax)
Series of 4 (2, 4, 6 months and 6 years)
1) Inactivated ____ vaccine (IPV) for all four vaccines scheduled above
2) Oral _____ vaccine (OPV) is discouraged and only possible for dose number 3 and 4
Polio Vaccine (IPV)
One dose of this is ________ annually
1) beginning at 6 months
2) in children 6 to 35 months of age, the dose = 0.25 ml intramuscularly; for children greater or equal to 3 years =0.50 ml intramuscular
Influenza Vaccine
Children younger than 9 years receive two doses 1 month apart for this vaccine
Influenza Vaccine
This vaccine is a series of 2 ( 1 year and by 12 years) abbreviated as MMR
Measles, Mumps, and rubella (MMR)
___, ____, ______
1) If exposed to this or traveling to endemic areas, can give this vaccine as early as 6 months of age, but the patient will need to continue primary series at the appropriate time.
2) May be given simultaneously with TB testing with purified protein derivative (PPD) but prefer to postpone PPD for 4 to 6 weeks to avoid possible suppressive response to PPD
Measles, Mumps, and Rubella (MMR)
_____ series of 2 (between 12 months and 12 years, minimum 3 months apart
1) Give two doses after the age of 12 months when no reliable history of chick pox and no evidence of immunity is available
2) Prefer to separate by 1 month from MMR vaccine
Varicella
Hepatitis ______ Vaccine
Series of 2 ( 1 year of 2 years, 6 months apart)
A
______ vaccine is a series of 2 ( age 11 to 12 years and a booster at the age of 16 years)
There is an increased rate of meningococcal disease between 16 to 21 year of age
Meningococcal Vaccine
Meningococcal conjugate vaccine MCV4 and what two names?
Menactra, Menveo
Adolescence receiving MCV4 ____ dose at or after 16 years, no booster necessary
first
This vaccine is a series of 2 (11 to 14 years; a second dose is given at 6 to 12 months after the first dose); series of 3 (15 to older; second dose give at 1 to 2 months, the Third dose give at 6 months
1) Most common sexually transmitted disease
2) Males and females
3) Gardasil 9 is only preparation commercially available; covers cervical, vulvar, vaginal and anal cancer caused by HPV ( 7 types); precancerous or dysplastic lesions ( 9 HPV Types); and genital warts ( 2 HPV Types)
4) It is recommended that adolescents sit for a least 15 minutes after receiving the vaccine due to risk of labile syncope, postural hypotension, and vasovagal response
Human Papillomavirus Vaccine (HPV)
If there is a break in immunization from the recommended schedule, ______ immunizations according to the child’s current age regardless of the vaccines previously missed
resume
Adverse reactions are typically minor usually involving what?
A. Local ______ soreness
B. Low ______ Temperature
C. Local ______ and tenderness
A. Muscle
B. grade
C. Erythema
_____ is contraindicated in those with a history of anaphylaxis to streptomycin
IPV
_____ should not be given to those who are pregnant or immunosuppressed
MMR
______ contraindicated in pregnant women and immunocompromised persons; contraindicated in those with streptomycin allergy
Varicella
_______ vaccine may be contraindicated in those with an egg allergy
Influenza vaccine
Reportable events with vaccine adverse events reported system
a.
b.
c.
a. anaphylaxis
b. encephalitis
c. death
